S. Saavedra

发表

Renal microtophi in a patient with lupus nephritis and tophaceous gout.

S. Navarra, S. Saavedra, A. Cayco, 2001, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Marked reduction in the incidence of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation with CD34+ positive selection

I. Jarque, J. Rubia, G. Sanz, 2001, Bone Marrow Transplantation.

FcγRIIb expression in early stage chronic lymphocytic leukemia

E. Montserrat, J. Delgado, J. Sierra, 2017, Leukemia & lymphoma.

Impact of Individual Comorbidities on Survival of Patients with Myelofibrosis

F. Cervantes, A. Angona, J. Hernández-Boluda, 2022, Cancers.

AB1109 CHARACTERIZATION OF PATIENTS WITH INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES (IPAF) AND ITS COMPARISON WITH PATIENTS WITH SCLERODERMA-RELATED INTERSTITIAL LUNG DISEASE AND WITH IDIOPATHIC FIBROSIS

K. Vergara, Caterina Chesta, S. Saavedra, 2019, Abstracts Accepted for Publication.

P. Bolufer, E. Barragán, J. Cervera, 2001, Bone Marrow Transplantation.

Bone marrow fibrosis, sequence variant of asxl1, and Sjögren syndrome: A case report

J. Nomdedéu, E. Bussaglia, C. Martínez, 2020, Clinical case reports.

Delay of onset of candidemia and emergence of Candida krusei fungemia in hematologic patients receiving prophylactic fluconazole.

M. Sanz, J. Pemán, I. Jarque, 2000, Haematologica.

Infectious complications in patients undergoing unrelated donor bone marrow transplantation: experience from a single institution.

M. Sanz, J. Pemán, J. de la Rubia, 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Cutaneous promyelocytic sarcoma at sites of vascular access and marrow aspiration. A characteristic localization of chloromas in acute promyelocytic leukemia?

J. Cervera, M. Sanz, J. de la Rubia, 2000, Haematologica.

Chronic Lymphocytic Leukemia: Clinical Stages Maintain Their Prognostic Significance Over the Course of the Disease and Are Surrogates for Response to Therapy

J. Briones, J. Sierra, S. Brunet, 2018, Clinical lymphoma, myeloma & leukemia.

Feasibility of thiotepa addition to the fludarabine-busulfan conditioning with tacrolimus/sirolimus as graft vs host disease prophylaxis

F. Bosch, C. Solano, R. Martino, 2020, Leukemia and Lymphoma.

Incorporating posttransplant cyclophosphamide-based prophylaxis as standard-of-care outside the haploidentical setting: challenges and review of the literature

J. Briones, J. Sierra, S. Brunet, 2019, Bone Marrow Transplantation.

Early infections in adult patients undergoing unrelated donor cord blood transplantation

M. Salavert, M. Gobernado, I. Jarque, 2002, Bone Marrow Transplantation.

Immune reconstitution Early infections in adult patients undergoing unrelated donor cord blood transplantation

M. Salavert, G. Sanz, M. Gobernado, 2002 .

Severe infections after single umbilical cord blood transplantation in adults with or without the co‐infusion of CD34+ cells from a third‐party donor: results of a multicenter study from the Grupo Español de Trasplante Hematopoyético (GETH)

R. Martino, R. Duarte, J. García-Marco, 2015, Transplant infectious disease : an official journal of the Transplantation Society.

Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies.

P. Bolufer, E. Barragán, J. Cervera, 2001, Blood.

hematologic malignancies Standardized, unrelated donor cord blood transplantation in adults with

P. Bolufer, E. Barragán, J. Cervera, 2013 .

Single-unit umbilical cord blood transplantation from unrelated donors in adult patients with chronic myelogenous leukemia.

M. Sanz, J. Sanz, J. de la Rubia, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cord blood transplantation from unrelated donors in adults with high-risk acute myeloid leukemia.

M. Sanz, J. Sanz, J. de la Rubia, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Incidence, risk factors, and outcome of cytomegalovirus infection and disease in patients receiving prophylaxis with oral valganciclovir or intravenous ganciclovir after umbilical cord blood transplantation.

M. Sanz, J. Sanz, M. Salavert, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Recent improvements in outcome for elderly patients with de novo acute myeloblastic leukemia.

J. Cervera, M. Sanz, J. de la Rubia, 2001, Leukemia research.

When an HLA identical donor is not available in adults with hematological neoplasms: single-center comparison of single-unit cord blood transplantation and haploidentical-related PBSC transplantation with PTCy using a standardized conditioning platform (thiotepa-busulfan-fludarabine)

J. Briones, J. Sierra, S. Brunet, 2019, Annals of Hematology.

Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab

J. Briones, S. Brunet, R. Martino, 2015, Bone Marrow Transplantation.

I. Jarque, J. Rubia, C. Jiménez, 2001, Bone Marrow Transplantation.

Impact of Cyclosporine Levels on the Development of Acute Graft versus Host Disease after Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation

J. Briones, J. Sierra, S. Brunet, 2014, Mediators of inflammation.

Updated experience with inolimomab as treatment for corticosteroid-refractory acute graft-versus-host disease.

J. Briones, J. Sierra, S. Brunet, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Successful Outcome in Patients with Myelofibrosis Undergoing Allogeneic Donor Hematopoietic Cell Transplantation Using Reduced-Doses of Post-Transplant Cyclophosphamide: challenges and review of the literature.

J. Briones, R. Martino, S. Miqueleiz, 2023, Transplantation and cellular therapy.

Sequence matters: Total body irradiation (TBI)‐based myeloablative conditioning with post‐transplant cyclophosphamide may reduce the early nonrelapse mortality compared with pretransplant cyclophosphamide plus TBI

J. Briones, R. Martino, S. Miqueleiz, 2023, European journal of haematology.

Outcome improvement over time in reduced intensity conditioning hematopoietic transplantation: a 20-year experience

A. Esquirol, A. Caballero, A. Garrido, 2023, Annals of hematology.

Evolution in the frontline treatment of patients with chronic lymphocytic leukemia: experience from one European center

R. Martino, J. Sierra, S. Novelli, 2023, Leukemia & lymphoma.